Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...

Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...

A positive mindset and resilience are crucial in overcoming the challenges of a cancer diagnosis and can be cultivated ...

Many childhood cancer survivors do not receive essential follow-up care, and researchers from the Keck School of Medicine of ...

The U.S. Food and Drug Administration (FDA) has cleared an investigational new drug application for a registrational phase 3 clinical trial of iSCIB1+ for patients with advanced melanoma, a step that ...

Discover inspiring messages of hope from cancer survivors, emphasizing resilience, scientific advancements, and the ...

Explore the evolving landscape of myeloma treatment, focusing on maintenance therapies and patient experiences with ...